A methodologic framework for modeling and assessing biomarkers of environmental enteropathy as predictors of growth in infants: An example from a Peruvian birth cohort

Josh M. Colston, Pablo Peñataro Yori, Elizabeth Colantuoni, Lawrence H. Moulton, Ramya Ambikapathi, Gwenyth Lee, Dixner Rengifo Trigoso, Mery Siguas Salas, Margaret N. Kosek

Research output: Contribution to journalArticle

Abstract

Background: Environmental enteropathy (EE) impairs the gut's absorptive capacity and immune function and causes decelerations in statural growth that manifest gradually over time. Objective: To illustrate an approach for assessing emerging biomarkers of EE, we separately assessed the associations between 3 such markers and subsequent nutritional status. Design: Stool samples were routinely collected between January 2010 and November 2014 from a cohort of 303 Peruvian infants and analyzed for concentrations of the biomarkers a-1-antitrypsin (AAT), myeloperoxidase, and neopterin. For each marker, a mixed-effects linear regression model was fitted for length-forage z scores (LAZs) obtained from anthropometric assessments that incorporated covariate predictors, polynomial terms for age, and product interaction terms to test associations over varying lag lengths. The biomarkers' contribution to the models was assessed with the use of the likelihood ratio test and partial R2 statistics. Results: Test statistics for the combined inclusion of the 4-model terms that involved the biomarker were highly statistically significant for AAT (28.71; P <0.0001) and myeloperoxidase (62.79; P <0.0001) over a 3-mo lag and moderately so for neopterin (13.97; P = 0.0074). AAT and myeloperoxidase seemed to interact strongly with age, with the magnitude and direction of the effect varying considerably over the first 3 y of life. The largest proportion of the variance explained by any biomarker (2.8%) and the largest difference in LAZ predicted between the 5th and 95th percentile (0.25) was by myeloperoxidase over a 2-mo lag. Conclusions: Of the 3 fecal biomarkers studied, 2 that related to intestinal function-AAT and myeloperoxidase-were associated with small but highly statistically significant differences in future statural growth trajectories in infants in this cohort, lending further evidence to the EE hypothesis that increased gut permeability and inflammation adversely affects subsequent nutritional status. This association exhibited a complex interaction with age. This trial was registered at clinicaltrials.gov as NCT02441426. Am J Clin Nutr 2017;106:245-55.

Original languageEnglish (US)
Pages (from-to)245-255
Number of pages11
JournalAmerican Journal of Clinical Nutrition
Volume106
Issue number1
DOIs
StatePublished - Jul 1 2017

Fingerprint

Biological Markers
Peroxidase
Neopterin
Nutritional Status
Linear Models
Permeability
Inflammation

Keywords

  • Biomarkers
  • Environmental enteropathy
  • MAL-ED
  • Mixed-effects model
  • Nutritional status
  • Peru

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Colston, Josh M.; Yori, Pablo Peñataro; Colantuoni, Elizabeth; Moulton, Lawrence H.; Ambikapathi, Ramya; Lee, Gwenyth; Trigoso, Dixner Rengifo; Salas, Mery Siguas; Kosek, Margaret N. / A methodologic framework for modeling and assessing biomarkers of environmental enteropathy as predictors of growth in infants : An example from a Peruvian birth cohort.

In: American Journal of Clinical Nutrition, Vol. 106, No. 1, 01.07.2017, p. 245-255.

Research output: Contribution to journalArticle

@article{7e44c6f5880445cbb2cd13efa32edf7f,
title = "A methodologic framework for modeling and assessing biomarkers of environmental enteropathy as predictors of growth in infants: An example from a Peruvian birth cohort",
abstract = "Background: Environmental enteropathy (EE) impairs the gut's absorptive capacity and immune function and causes decelerations in statural growth that manifest gradually over time. Objective: To illustrate an approach for assessing emerging biomarkers of EE, we separately assessed the associations between 3 such markers and subsequent nutritional status. Design: Stool samples were routinely collected between January 2010 and November 2014 from a cohort of 303 Peruvian infants and analyzed for concentrations of the biomarkers a-1-antitrypsin (AAT), myeloperoxidase, and neopterin. For each marker, a mixed-effects linear regression model was fitted for length-forage z scores (LAZs) obtained from anthropometric assessments that incorporated covariate predictors, polynomial terms for age, and product interaction terms to test associations over varying lag lengths. The biomarkers' contribution to the models was assessed with the use of the likelihood ratio test and partial R2 statistics. Results: Test statistics for the combined inclusion of the 4-model terms that involved the biomarker were highly statistically significant for AAT (28.71; P <0.0001) and myeloperoxidase (62.79; P <0.0001) over a 3-mo lag and moderately so for neopterin (13.97; P = 0.0074). AAT and myeloperoxidase seemed to interact strongly with age, with the magnitude and direction of the effect varying considerably over the first 3 y of life. The largest proportion of the variance explained by any biomarker (2.8%) and the largest difference in LAZ predicted between the 5th and 95th percentile (0.25) was by myeloperoxidase over a 2-mo lag. Conclusions: Of the 3 fecal biomarkers studied, 2 that related to intestinal function-AAT and myeloperoxidase-were associated with small but highly statistically significant differences in future statural growth trajectories in infants in this cohort, lending further evidence to the EE hypothesis that increased gut permeability and inflammation adversely affects subsequent nutritional status. This association exhibited a complex interaction with age. This trial was registered at clinicaltrials.gov as NCT02441426. Am J Clin Nutr 2017;106:245-55.",
keywords = "Biomarkers, Environmental enteropathy, MAL-ED, Mixed-effects model, Nutritional status, Peru",
author = "Colston, {Josh M.} and Yori, {Pablo Peñataro} and Elizabeth Colantuoni and Moulton, {Lawrence H.} and Ramya Ambikapathi and Gwenyth Lee and Trigoso, {Dixner Rengifo} and Salas, {Mery Siguas} and Kosek, {Margaret N.}",
year = "2017",
month = "7",
doi = "10.3945/ajcn.116.151886",
volume = "106",
pages = "245--255",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "1",

}

TY - JOUR

T1 - A methodologic framework for modeling and assessing biomarkers of environmental enteropathy as predictors of growth in infants

T2 - American Journal of Clinical Nutrition

AU - Colston,Josh M.

AU - Yori,Pablo Peñataro

AU - Colantuoni,Elizabeth

AU - Moulton,Lawrence H.

AU - Ambikapathi,Ramya

AU - Lee,Gwenyth

AU - Trigoso,Dixner Rengifo

AU - Salas,Mery Siguas

AU - Kosek,Margaret N.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Background: Environmental enteropathy (EE) impairs the gut's absorptive capacity and immune function and causes decelerations in statural growth that manifest gradually over time. Objective: To illustrate an approach for assessing emerging biomarkers of EE, we separately assessed the associations between 3 such markers and subsequent nutritional status. Design: Stool samples were routinely collected between January 2010 and November 2014 from a cohort of 303 Peruvian infants and analyzed for concentrations of the biomarkers a-1-antitrypsin (AAT), myeloperoxidase, and neopterin. For each marker, a mixed-effects linear regression model was fitted for length-forage z scores (LAZs) obtained from anthropometric assessments that incorporated covariate predictors, polynomial terms for age, and product interaction terms to test associations over varying lag lengths. The biomarkers' contribution to the models was assessed with the use of the likelihood ratio test and partial R2 statistics. Results: Test statistics for the combined inclusion of the 4-model terms that involved the biomarker were highly statistically significant for AAT (28.71; P <0.0001) and myeloperoxidase (62.79; P <0.0001) over a 3-mo lag and moderately so for neopterin (13.97; P = 0.0074). AAT and myeloperoxidase seemed to interact strongly with age, with the magnitude and direction of the effect varying considerably over the first 3 y of life. The largest proportion of the variance explained by any biomarker (2.8%) and the largest difference in LAZ predicted between the 5th and 95th percentile (0.25) was by myeloperoxidase over a 2-mo lag. Conclusions: Of the 3 fecal biomarkers studied, 2 that related to intestinal function-AAT and myeloperoxidase-were associated with small but highly statistically significant differences in future statural growth trajectories in infants in this cohort, lending further evidence to the EE hypothesis that increased gut permeability and inflammation adversely affects subsequent nutritional status. This association exhibited a complex interaction with age. This trial was registered at clinicaltrials.gov as NCT02441426. Am J Clin Nutr 2017;106:245-55.

AB - Background: Environmental enteropathy (EE) impairs the gut's absorptive capacity and immune function and causes decelerations in statural growth that manifest gradually over time. Objective: To illustrate an approach for assessing emerging biomarkers of EE, we separately assessed the associations between 3 such markers and subsequent nutritional status. Design: Stool samples were routinely collected between January 2010 and November 2014 from a cohort of 303 Peruvian infants and analyzed for concentrations of the biomarkers a-1-antitrypsin (AAT), myeloperoxidase, and neopterin. For each marker, a mixed-effects linear regression model was fitted for length-forage z scores (LAZs) obtained from anthropometric assessments that incorporated covariate predictors, polynomial terms for age, and product interaction terms to test associations over varying lag lengths. The biomarkers' contribution to the models was assessed with the use of the likelihood ratio test and partial R2 statistics. Results: Test statistics for the combined inclusion of the 4-model terms that involved the biomarker were highly statistically significant for AAT (28.71; P <0.0001) and myeloperoxidase (62.79; P <0.0001) over a 3-mo lag and moderately so for neopterin (13.97; P = 0.0074). AAT and myeloperoxidase seemed to interact strongly with age, with the magnitude and direction of the effect varying considerably over the first 3 y of life. The largest proportion of the variance explained by any biomarker (2.8%) and the largest difference in LAZ predicted between the 5th and 95th percentile (0.25) was by myeloperoxidase over a 2-mo lag. Conclusions: Of the 3 fecal biomarkers studied, 2 that related to intestinal function-AAT and myeloperoxidase-were associated with small but highly statistically significant differences in future statural growth trajectories in infants in this cohort, lending further evidence to the EE hypothesis that increased gut permeability and inflammation adversely affects subsequent nutritional status. This association exhibited a complex interaction with age. This trial was registered at clinicaltrials.gov as NCT02441426. Am J Clin Nutr 2017;106:245-55.

KW - Biomarkers

KW - Environmental enteropathy

KW - MAL-ED

KW - Mixed-effects model

KW - Nutritional status

KW - Peru

UR - http://www.scopus.com/inward/record.url?scp=85021786335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021786335&partnerID=8YFLogxK

U2 - 10.3945/ajcn.116.151886

DO - 10.3945/ajcn.116.151886

M3 - Article

VL - 106

SP - 245

EP - 255

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 1

ER -